To Download a copy of the presentation click here.
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000574). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts:
CDC Update & Setting the Stage: The Use of Serology Testing to Guide Clinical Decision-Making
Adi Gundlapalli, MD, PhD
CDC COVID-19 Response Team
Chief Public Health Informatics Officer, Center for Surveillance, Epidemiology, and Laboratory Services
U.S. Centers for Disease Control and Prevention
FDA Update
Ryan Karsner, MD
Medical Officer, Division of Microbiology Devices
Office of In Vitro Diagnostics and Radiological Health
Office of Health Technology 7
Center for Devices and Radiological Health
U.S. Food and Drug Administration
Patterns of Testing at Mayo Clinic
Elitza S. Theel, PhD, D(ABMM)
Director, Infectious Diseases Serology Laboratory
Co-Director Vector-Bourne Diseases Laboratory Service Line
Professor, Laboratory Medicine and Pathology
Division of Clinical Biology
Mayo Clinic
The Clinical Perspective: Using Serology Test to Guide Clinical Decision-Making
Ghady Haidar, MD
Director of Research, Bone Marrow Transplant and Hematological Malignancy Infectious Diseases
Program Director of the Transplant Infectious Diseases Fellowship Program
University of Pittsburgh
Key Considerations & Future Directions in Serology Testing
Florian Krammer, PhD
Professor of Vaccinology, Department of Microbiology
Icahn School of Medicine at Mount Sinai
